AFSI BPHX VSR

Versar Inc.

VSR is small cap biotech company which has a great upside momemtum and short term target $20.

BluePhoenix Solutions, Ltd.

BPHX has great technology in line , testing at 50dma.Long term target $20, And its a buy on pull backs.

Amtrust Financial Services (Revisting)

Good support @ 100 DMA and market correction has made this position a buy Medium term target $25

Next week tech analysis on RUSHA and HEM